PBS Makes Immunotherapy Cheaper and Easier to Access
03 Mar 2026
This could save more than 5,000 patients around $100,000 each per course.
For the first time, one PBS listing now covers several cancer types. Patients no longer face the “once-in-a-lifetime” rule, meaning those with rare cancers can access treatment without separate applications for each cancer.
Dr Rachel Roberts-Thomson, oncologist, said the change is a “turning point” in cancer care. Doctors can now prescribe the drugs based on who will benefit, not just the type of cancer.
Patients who may benefit include those with advanced or metastatic cancers, cancers that cannot be removed surgically, or those needing repeated treatment.
Christine Cockburn, CEO of Rare Cancers Australia, said it gives “equity and hope” to patients who previously faced huge costs.
Health Minister Mark Butler described it as a “landmark extension” to the PBS, giving thousands of Australians new hope.
https://www1.racgp.org.au/
Source: ABC News